Materialise NV has released its financial results for the third quarter of 2026, revealing a modest revenue increase but a decline in overall profits. The company reported total revenue of 67,670 kEUR, a 2.1% rise from 66,259 kEUR in the same quarter of 2025. However, net profit fell to 1,383 kEUR from 1,848 kEUR year-over-year, indicating challenges in managing rising expenses.

The results are significant for Materialise, a company that specializes in 3D printing software and services. The increase in revenue was primarily driven by a 9.7% growth in its Medical segment, which generated 36,542 kEUR compared to 33,296 kEUR in Q3 2025. In contrast, revenue from the Software segment decreased to 9,864 kEUR from 10,286 kEUR, and the Manufacturing segment also saw a drop from 22,677 kEUR to 21,266 kEUR.

Background

Materialise NV operates in the prepackaged software sector, specifically focusing on 3D printing solutions. The company is listed on the Nasdaq under the ticker MTLS and is classified under the SIC code 7372. Materialise has a strong presence in various industries, including healthcare, automotive, and aerospace, leveraging its extensive experience in 3D printing.

What the Filing Says

The filing indicates that gross profit for the third quarter increased by 3.7% to 39,035 kEUR, with a gross profit margin of 57.7%, up from 56.8% in the previous year. However, the company faced rising operational costs, with total expenses increasing by 7.8% to 38,830 kEUR, primarily due to a significant rise in research and development spending, which increased by 11.9%.

Despite these challenges, Materialise reported a net operating income of 1,343 kEUR, down from 2,522 kEUR in Q3 2025. The company also noted that it had repurchased 1,426,784 shares for a total of 7,482 kEUR under its share buy-back program.

Impact

The results may affect various stakeholders, including investors, employees, and customers. Investors may be concerned about the declining profit margins and increasing expenses, while employees may face pressure to improve operational efficiency. Customers could see continued innovation in the Medical segment, which remains a key growth area for the company.

What's Next

The filing does not specify what happens next for Materialise, but the company is likely to continue focusing on its R&D initiatives and managing its operational costs to improve profitability in future quarters.